NCT00343707View on ClinicalTrials.gov

PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Depressive Disorder and Anxiety Disorders

Interventions

DRUG

vestipitant

DRUG

paroxetine

Trial Locations (1)

SE-753 23

GSK Investigational Site, Uppsala

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00343707 - PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients | Biotech Hunter | Biotech Hunter